MDA grants

Research and clinical trial updates

posted on October 8, 2015 - 9:23am
Towards Treatments and Cures New grants pave the way to progress
posted on October 3, 2013 - 9:15am
Quest Vol. 20, No. 4
In its Summer 2013 round of grants, MDA awarded 31 new grants totaling $8.5 million. 

Research progress in one disease can lead to progress in other diseases — and MDA’s latest round of grants seek to leverage this potential

posted on August 21, 2013 - 1:35pm
In its summer 2013 round of research grant awards, the Muscular Dystrophy Association aims to catalyze research progress in a dozen neuromuscular diseases, with an eye toward applying that knowledge to related muscle diseases, as well. “A large number of our grants are investigating new therapeutic technologies,” notes Jane Larkindale, MDA's vice president of research. “These are 'platform'...

The search for therapies and cures must be accompanied by the cultivation of the best and brightest researchers

posted on October 1, 2011 - 3:33pm
QUEST Vol. 18, No. 4
All MDA grants have the same basic goal: moving promising treatments through the “drug development pipeline,” from early discoveries in the lab, to clinical trials, to actual therapies that can be prescribed in the clinic. But some MDA grants are designed to accomplish this goal not only by funding research but by encouraging the “best and the brightest” young scientists to become future...

New MDA grants recently were approved for several forms of muscular dystrophy, ALS, Friedreich’s ataxia, myasthenia gravis and other diseases in MDA's program.

posted on January 6, 2010 - 4:59pm
In December 2009, MDA awarded $21 million in new research grants for neuromuscular disease research. MDA's Scientific Advisory Committee (SAC) and Medical Advisory Committee (MAC) meet each fall and spring to review applications for research grants. Applications are scored on the basis of the capabilities of the applicant, the scientific merit of the project, and the proposal's relevance to...